Search

List Grid

81-90 of 10,993 results

  • Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive

    News Release

    Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds. The Trump administration has promoted the TrumpRx website as a way for consumers to get the lowest prices for prescription medications in the world, drawing on…

  • Board of Trustees

    Page

    KFF Board of Trustees KFF’s trustees have deep backgrounds in public service, academia, nonprofit organizations, health care, and the media. Trustees serve two, five-year terms. The KFF Board is currently chaired by former Senator, Olympia Snowe. Jim Canales, president and trustee of the Barr Foundation, serves as Vice Chair. Drew Altman, PhD President and Chief Executive Officer, KFF James E. Canales (Vice-Chair) President & Trustee, Barr Foundation Frederick P. Cerise, MD, MPH President and Chief…

  • Women’s Health Care Affordability Challenges

    Issue Brief

    As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts in spending on basic needs.

  • KFF/AP Rural Voters Survey

    Poll Finding

    The KFF/AP Rural Voters Survey examines the views and political priorities of voters living in rural areas across the United States ahead of the 2026 midterm elections. The survey gauges rural voters' top election issues, growing struggles with cost of living and health care costs, as well as views on the Trump administration's health care policies.

  • AI: To Regulate, or Not to Regulate?

    Podcast

    Across the tech industry, many of AI's own leaders are calling for oversight — self-imposed or from government. That debate is on, but where it will land is anyone's guess. Joe Grogan takes a different tack: the biggest threat in health care AI may not be too little regulation, but the wrong kind.